SCHEMBL3415731

SCHEMBL3415731

Cc1cccc(C(CNC2=NCCO2)c2ccccc2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.43
CFB P00751 1/20 0.38
ADRA2A P08913 10/20 0.36
ADRA2B P18089 8/20 0.36
ADRA2C P18825 7/20 0.36
ADRA1A P35348 3/20 0.34
CYP2D6 P10635 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
SLC22A2 O15244 1/20 0.33
SLC22A1 O15245 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
DRD1 P21728 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3670065 0.86 TAAR1 (0.38) TAAR1CFBADRA2AADRA2BADRA2C
SCHEMBL3667158 0.85 TAAR1 (0.40) TAAR1CFBADRA2AADRA2BADRA2C
SCHEMBL3433522 0.83 CFB (0.41) TAAR1CFBADRA2AADRA1ASLC6A2
SCHEMBL3411857 0.79 CFB (0.36) TAAR1CFBADRA2AADRA2BADRA2C
SCHEMBL3415435 0.76 LMNA (0.48) TAAR1CYP2D6CYP3A4LMNABLM
SCHEMBL3414027 0.75 CFB (0.39) TAAR1CFBADRA2AADRA2BADRA2C
SCHEMBL3415726 0.75 TAAR1 (0.40) TAAR1CFBADRA2AADRA2BADRA2C
SCHEMBL3415102 0.74 CFB (0.34) TAAR1CFBADRA2AADRA2BADRA2C
SCHEMBL3666286 0.73 SLC6A3 (0.43) ADRA2AADRA2BADRA2CCYP2C19CYP3A4
SCHEMBL3415420 0.73 ADRA2A (0.41) TAAR1CFBADRA2AADRA1ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265269-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF Allergan, Inc. (US) 2010-12-29 EP disclosed
WO-2009120648-A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF ALLERGAN, INC. (US) 2009-10-01 WO disclosed